The current debate on the next EU Framework Programme for Research and Innovation (FP9) offers the opportunity to articulate a long-term vision for biomedical and health research, and to address current gaps in support of excellent science.
A European Union that ensures patient access and sustainability
Date
03 Mar 2020 14:30 to 18:00
Address
Permanent Representation of Hungary to the EU
92-98 Rue de Treves
Brussels
BelgiumSection
Health & Consumers
Event Location
Brussels
Event Description
14h30 - Registration and welcome
15h00 - Welcome address
- Dr. Tibor STELBACZKY, Ambassador Plenipotentiary, Deputy Permanent Representative of Hungary to the European Union
15h05 - Keynote address
- Mr. Goran ŠTEFANIĆ, Ambassador Plenipotentiary, Deputy Permanent Representative of Croatia to the EU
15h10 - Keynote address
- Christoph Stoller, President Medicines for Europe
15h15 - Introductory speeches
- Breaking down silos for safe, effective and affordable medicines Sylvain Giraud - Head of Unit, Performance of national health systems, Directorate-General for Health and Food Safety, European Commission
- Access to pharmaceuticals in CEE: potential to fulfil unmet needs Zoltán Kaló - Professor of Health Economics, Center for Health Technology Assessment, Semmelweis University
- The new Commission vision in ensuring equitable and sustainable access Olga Solomon - Head of Unit Medicines: policy, authorisation and monitoring, Directorate General for Health and Food Safety, European Commission
15h45 - PANEL I: Overcoming access barriers to oncology treatment
- Valerie Paris - Organisation for Economic Co-operation and Development (OECD)
- Zoltán Kaló - Professor of Health Economics, Center for Health Technology Assessment, Semmelweis University
- Rosa Giuliani - Director of Public Policy, European Society of Medical Oncology (ESMO)
- Vera Pataki - Chair of the CEE Network, Medicines for Europe
- Beata Ambroziewicz - Board of the European Cancer Patient Coalition and President of Polish Union of Patient Organisations - (tbc)
16h45 - Coffee Break
17h00 - PANEL II: Maintaining generic medicines availability and preventing shortages
- Ilka Wölfle - President, European Social Insurance Platform
- Adrian van den Hoven - Director General, Medicines for Europe
- Stephanie Kohl - Policy and Advocacy Officer, European Association of Hospital Pharmacists (EAHP)
18h00 - Closing remarks
- Edina TÓTH - Member of the Environment, Public health and Food safety Committee of the European Parliament (EPP)
- Christoph Stoller - President Medicines for Europe Moderator all sessions: Aidan Fry, Stada and former editor at Informa (tbc)
18h50 - A cocktail reception will follow the seminar
Related Events
20 Mar 2018
On Tuesday, March 20th, 2018, the Global Sepsis Alliance, jointly with EU Commissioner for Health and Food Safety, Vytenis Andriukaitis, will host the event 'Sepsis - The Most Prev
25 Jan 2018 to 26 Jan 2018
Big data is revolutionising healthcare and it is at our fingertip! Find out how to get onboard the movement that is fast transforming the way we live and work!
23 Jan 2018 to 25 Jan 2018
The MedTech Forum is one of the largest health and medical technology industry conference in Europe and a key event since 2007.
06 Dec 2017
It is undeniable that European health and care systems are in need of substantial reform if they are to address the challenges posed by the demographic shift to an ageing society and the increasing burden of chronic diseases and related co-morbidities this brings.
05 Dec 2017
The European Cancer Patient Coalition, together with MEP Marlene Mizzi (S&D, Malta), is organising an event on the topic of Cancer Biomarkers in the Era of Personalised Medicines.
22 Nov 2017
Ten years after the European Commission’s “White paper on a Strategy for Europe on Nutrition, Overweight and Obesity-related health issues”, the European Snacks Association gathers stakeholders to discuss the lessons learned and explore ways of building consensus on eff
22 Nov 2017
Many stakeholders believe innovation only leads to generating new molecules, but innovation can also come from other areas such as focusing on improving present molecules which are no longer protected by patent.
14 Nov 2017
There are currently over 200 million women living with diabetes and this total is projected to increase to more than 300 million by 2040. Diabetes is the ninth leading cause of death in women globally, causing 2.1 million deaths each year.
06 Nov 2017
Welcome to Rud Pedersen’s Fourth Healthcare Seminar, focusing on trends in European Healthcare Policy.
Cercle de Lorraine, Brussels 6 November 2017, 14:00-16:30
06 Nov 2017
The Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium (BBMRI-ERIC) is hosting a seminar to assess the impact of the GDPR on FP9 health research and examine how the Code of Conduct for Health Research being developed by BBMRI-ERIC a
19 Oct 2017
Hosted by MEP Heinz K. Becker (EPP, Austria)
17 Oct 2017
European Policy Response to Metastatic Breast Cancer
Tuesday 17th October 2017, 12.00-14.00 CET
27 Sep 2017
Consumer rights
Sustainable agriculture, safer food, strong rural communities
At the European Parliament in Brussels in room A3G-3.
On Wednesday 27 September 2017 from 14h30 - 17h30.
18 Sep 2017
20 Jun 2017
On the 20th of June 2017, Brussels will become the capital of Flavour.
20 Jun 2017 to 22 Jun 2017
Skin Cancer: Safe Work Under the Sun
25 Apr 2017
The European Parliament Interest Group on Allergy and Asthma invites you to the policy symposium “United Action for Allergy and Asthma” at the Europea
20 Apr 2017 to 21 Apr 2017
08 Feb 2017
“European policy response to rare cancers: the case of sarcoma”
8th February 2017, 14h30-16h30
European Parliament, Altiero Spinelli building, room A5E-2, Brussels
Pages
Events of the week
Jobs
WeMove Europe
Positive Money Europe
EuropaBio
White Research
White Research
European Macro Policy Network (EMPN)
Handelsverband Deutschland HDE e.V.
CLASP
EURACTIV News
- Commission working on study to develop AI model energy efficiency framework [Advocacy Lab Content]
- EU’s energy transition resilience needs action, gas infrastructure funding [Advocacy Lab Content]
- EU must invest quickly in Kazakhstan’s rare earths production, for green energy transition and global competition [Advocacy Lab Content]
- Rising distrust of news and journalists is risking lives, media freedom in EU [Advocacy Lab Content]
- German industry boss warns: Europe could be hit next by Trump tariff threats